Insider · CIK 0001786391
Benjamin J. Hindson
officerdirector
Files at TXG (10x Genomics, Inc.). First filing Nov 25, 2024, latest Aug 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $295k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXG: 10x Genomics, Inc.
TXGOct 9, 2026 · close 80.65
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | 10x Genomics, Inc. | $103k 7,486 shares | -2% | +100% from low-39% from high | |
| 37Weak | 10x Genomics, Inc. | $62k 7,485 shares | -2% | +20% from low-64% from high | |
| 30Weak | 10x Genomics, Inc. | $51k 4,573 shares | -1% | +4% from low-52% from high | |
| 32Weak | 10x Genomics, Inc. | $79k 5,807 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -7,486 | $13.79 | $103k | 440,888 | Aug 26, 2025 |
| May 22, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -7,485 | $8.30 | $62k | 448,374 | May 27, 2025 |
| Mar 17, 2025 | TXG 10x Genomics, Inc. | AGrant or award Class A Common Stock | +120,535 | $0.00 | $0 | 455,859 | Mar 19, 2025 |
| Feb 24, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -4,573 | $11.07 | $51k | 335,324 | Feb 26, 2025 |
| Nov 22, 2024 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -5,807 | $13.69 | $79k | 339,897 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.